Connecticut leads 20-state lawsuit over drug pricing

HARTFORD  — Connecticut is leading a 20-state lawsuit against six generic drug-makers, alleging they artificially inflated and manipulated prices to reduce competition for an antibiotic and oral diabetes medication. The lawsuit was filed Thursday in U.S. District Court in Connecticut. Portions of the complaint are redacted because there are ongoing investigations into the matter. Connecticut Attorney General George Jepsen says his office began its probe more than two years ago and &ld